REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/22/2025
Back to search
Official data from USPTO
DERMAL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DERMAL THERAPEUTICS
ST13
US500000090070109Class
5
Filing
90070109
Registration
6230606
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
12
Latest update
12/23/2025
Trademark type
Word
Nice classes
5
Filing date
07/23/2020
Registration date
12/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2020
Last transaction
12/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
06/15/2020
First use in commerce
06/15/2020
Drawing code
4
Owner type
16
Owner location
Reno, NV
Examiner
FITZSIMONS,MICHAEL R
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DT IP HOLDINGS I LLC
Representatives
DAVID GUILFORD GUILFORD LEGAL GROUP PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements in the form of transdermal gels; Delivery agents in the form of transdermal gels that facilitate the delivery of nutritional supplements
Publications
History of USPTO decisions and trademark events.
12 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/22/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/18/2020
ALIE
ASSIGNED TO LIE
11/18/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/16/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/16/2020
DOCK
ASSIGNED TO EXAMINER
11/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2020
NWAP
NEW APPLICATION ENTERED
07/27/2020
Continuous trademark protection
Get notified about every new filing that threatens DERMAL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.